IPRATECH
ActiveHoldings and subsidiaries
3 holdingsHoldings 3
Source for every holding own accounts 2025
- APICELLS INCUSsubsidiaryEquity USD 56,852Result USD 6,030100%
- EMMAsubsidiaryEquity €8,381 Loss of €22,678 in 2025 (profit of €10,547 in 2024)100%
- IPRASENSE SASFRsubsidiaryEquity €925,328Result -€9,15781%
Acquisitions and mergers
1 transactionTook over:EMMA
Companies at the same address
3 other companiesConnections & network
2 connected companiesThe connected companies are in the list below.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
ACAPELA GROUP BABEL Technologies
via POSKIN Thierry · Director
→
MARSTRAND
via POSKIN Thierry · Permanent representative
→